371 related articles for article (PubMed ID: 25547241)
1. Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes.
Schwartz SS; DeFronzo RA; Umpierrez GE
Postgrad Med; 2015 Mar; 127(2):251-7. PubMed ID: 25547241
[TBL] [Abstract][Full Text] [Related]
2. Use of incretin-based therapy in hospitalized patients with hyperglycemia.
Umpierrez GE; Schwartz S
Endocr Pract; 2014 Sep; 20(9):933-44. PubMed ID: 25100362
[TBL] [Abstract][Full Text] [Related]
3. Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge.
Bode B; Amin A
Hosp Pract (1995); 2009 Dec; 37(1):7-21. PubMed ID: 20720383
[TBL] [Abstract][Full Text] [Related]
4. Transitioning from inpatient to outpatient therapy in patients with in-hospital hyperglycemia.
Peterson G
Hosp Pract (1995); 2011 Oct; 39(4):87-95. PubMed ID: 22056828
[TBL] [Abstract][Full Text] [Related]
5. Achieving glycemic goals with addition of incretin-based therapies to insulin in patients with type 2 diabetes mellitus.
Tibaldi J
Am J Med Sci; 2014 Jun; 347(6):491-501. PubMed ID: 24469234
[TBL] [Abstract][Full Text] [Related]
6. Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.
Boland CL; Degeeter M; Nuzum DS; Tzefos M
Ann Pharmacother; 2013 Apr; 47(4):490-505. PubMed ID: 23548652
[TBL] [Abstract][Full Text] [Related]
7. Focus on incretin-based therapies: targeting the core defects of type 2 diabetes.
Jellinger PS
Postgrad Med; 2011 Jan; 123(1):53-65. PubMed ID: 21293084
[TBL] [Abstract][Full Text] [Related]
8. Incretin therapies in the management of elderly patients with type 2 diabetes mellitus.
Bourdel-Marchasson I; Schweizer A; Dejager S
Hosp Pract (1995); 2011 Feb; 39(1):7-21. PubMed ID: 21441754
[TBL] [Abstract][Full Text] [Related]
9. Increased priority for regimens involving incretin-based and insulin therapy.
Rodbard HW
J Fam Pract; 2013 Dec; 62(12 Suppl CME):S5-11. PubMed ID: 24340348
[TBL] [Abstract][Full Text] [Related]
10. Incretin therapy and its effect on body weight in patients with diabetes.
Lind M
Prim Care Diabetes; 2012 Oct; 6(3):187-91. PubMed ID: 22613745
[TBL] [Abstract][Full Text] [Related]
11. The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins.
Schwartz S; DeFronzo RA
Curr Diab Rep; 2014 Mar; 14(3):466. PubMed ID: 24515252
[TBL] [Abstract][Full Text] [Related]
12. Insulin treatment for type 2 diabetes: when to start, which to use.
Hamaty M
Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
[TBL] [Abstract][Full Text] [Related]
13. Managing type 2 diabetes: going beyond glycemic control.
Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
[TBL] [Abstract][Full Text] [Related]
14. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
15. [Incretin and incretin-based therapies].
Harada N; Inagaki N
Nihon Rinsho; 2010 May; 68(5):931-42. PubMed ID: 20446595
[TBL] [Abstract][Full Text] [Related]
16. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
Nadeau DA
Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia management using insulin in the acute care setting: therapies and strategies for care in the non-critically ill patient.
Kirk JK; Oldham EC
Ann Pharmacother; 2010; 44(7-8):1222-30. PubMed ID: 20571106
[TBL] [Abstract][Full Text] [Related]
18. Incretin therapy for type 2 diabetes mellitus.
Klonoff DC
Adv Ther; 2010 Dec; 27(12):881-94. PubMed ID: 20978879
[TBL] [Abstract][Full Text] [Related]
19. Glycemic management in the inpatient setting.
Schmeltz LR; Ferrise C
Hosp Pract (1995); 2012 Apr; 40(2):44-55. PubMed ID: 22615078
[TBL] [Abstract][Full Text] [Related]
20. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists!
Schwartz S; DeFronzo RA
Diabetes Care; 2013 Jul; 36(7):2107-11. PubMed ID: 23801800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
